focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 161.00
Bid: 159.20
Ask: 160.20
Change: 5.80 (3.74%)
Spread: 1.00 (0.628%)
Open: 155.80
High: 161.00
Low: 154.80
Prev. Close: 155.20
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

15 Feb 2024 07:00

RNS Number : 1880D
Sabre Insurance Group PLC
15 February 2024
 

 

 

15 February 2024

 

Sabre Insurance Group plc

Trading Update

 

Sabre Insurance Group Plc ("Sabre" or the "Group"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the year ended 31 December 2023.

Since 2022 Sabre has taken rapid and decisive pricing actions to mitigate the on-going elevated claims inflation. Consequently, it now expects to deliver a strong result for 2023 as it continues to re-build toward its historical level of profitability.

The results are anticipated to meet or exceed current market expectations across almost all key measures, specifically:

- Gross Written Premium at c.£225m, representing 31% growth. Within this, core Motor Vehicle premium growth of circa 47%

- Profit to be towards or slightly above the upper end of current market expectations

- Strong capital generation leaving pre-dividend solvency capital ratio around 205%

Sabre is scheduled to present its audited full year results for 2023 on 19 March 2024.

 

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

FORWARD-LOOKING STATEMENTS DISCLAIMER

Cautionary statement

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect Sabre's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to Sabre's business, results of operations, financial position, prospects, growth or strategies and the industry in which it operates.

Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, Sabre disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

The Sabre Insurance Group plc LEI number is 2138006RXRQ8P8VKGV98.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDDDGBDGSS
Date   Source Headline
16th Apr 20202:57 pmRNSDirector/PDMR Shareholding
7th Apr 20203:45 pmRNSDirector/PDMR Shareholding
7th Apr 202012:02 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSFinal Results
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202012:23 pmRNSNotification of Results Announcement Date
24th Mar 20207:00 amRNSDelay of Full Year results announcement
20th Mar 20204:48 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 202012:07 pmRNSSecond Price Monitoring Extn
18th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 202010:45 amRNSDirector/PDMR Shareholding
9th Mar 202012:07 pmRNSSecond Price Monitoring Extn
9th Mar 202012:02 pmRNSPrice Monitoring Extension
28th Feb 202010:14 amRNSDirector Declaration
11th Feb 20203:07 pmRNSDirector/PDMR Shareholding
13th Jan 20201:53 pmRNSDirector/PDMR Shareholding
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
11th Dec 201911:41 amRNSDirector/PDMR Shareholding
22nd Nov 20198:50 amRNSHolding(s) in Company
12th Nov 20192:35 pmRNSDirector/PDMR Shareholding
6th Nov 20191:57 pmRNSHolding(s) in Company
22nd Oct 20194:55 pmRNSHolding(s) in Company
22nd Oct 20194:52 pmRNSHolding(s) in Company
15th Oct 201910:03 amRNSDirector/PDMR Shareholding
11th Oct 20193:12 pmRNSDirector/PDMR Shareholding
11th Oct 201910:58 amRNSDirector/PDMR Shareholding
10th Oct 20197:00 amRNSTrading Update
20th Sep 201911:14 amRNSDirector/PDMR Shareholding
11th Sep 201910:26 amRNSDirector/PDMR Shareholding
4th Sep 201910:57 amRNSHolding(s) in Company
13th Aug 201912:18 pmRNSDirector/PDMR Shareholding
9th Aug 201912:07 pmRNSSecond Price Monitoring Extn
9th Aug 201912:02 pmRNSPrice Monitoring Extension
31st Jul 20198:34 amRNSHolding(s) in Company
30th Jul 20197:00 amRNSHalf-year Report
11th Jul 20195:08 pmRNSDirector/PDMR Shareholding
29th May 20199:09 amRNSHolding(s) in Company
23rd May 201911:33 amRNSAGM Statement
23rd May 20197:00 amRNSTrading Statement
10th May 20194:49 pmRNSHolding(s) in Company
30th Apr 20194:16 pmRNSDirector/PDMR Shareholding
29th Apr 20194:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20195:04 pmRNSDirector/PDMR Shareholding
18th Apr 201911:18 amRNSNotice of AGM
12th Apr 20198:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.